Cardiac Success is developing the V-sling device to improve the lives of the millions of patients who, despite guidance-directed medical therapy, continue to suffer and deteriorate from Heart Failure with Reduced Ejection Fraction (HFrEF). The V-sling is a transcatheter ventricular repair device designed based on a successful surgical papillary muscle approximation procedure.
Member count: 1-10
Total raised: $16.561854M
Founded date: 2008
Investors 1
Date | Name | Website |
08.07.2021 | 415 Capita... | 415capital... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
12.01.2022 | - | $11.361854... | - | prweb.com/... |
23.06.2021 | Series A | $5.2M | - | finsmes.co... |
Mentions in press and media 4
Date | Title | Description | Category | Author | Source |
12.01.2022 | Cardiac Su... | YOKNEAM, Israel (PRWEB) Januar... | - | - | prweb.com/... |
24.06.2021 | Cardiac Su... | Cardiac Success Ltd., a Yoknea... | Israel | - | finsmes.co... |
24.06.2021 | Cardiac Su... | What You Should Know: – Cardi... | - | Jasmine Pe... | hitconsult... |
23.06.2021 | Israeli Me... | Boaz Manash, CEO at Cardiac Su... | - | - | prweb.com/... |